4//SEC Filing
Cataldi Fabio 4
Accession 0001209191-22-049038
CIK 0001785345other
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 5:09 PM ET
Size
5.5 KB
Accession
0001209191-22-049038
Insider Transaction Report
Form 4
Cataldi Fabio
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-09-05+400,000→ 400,000 totalExercise: $0.89Exp: 2032-09-04→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]25% of the shares of common stock underlying this option will vest and become exercisable on September 5, 2023 and the remaining shares of common stock underlying this option will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.
Documents
Issuer
Landos Biopharma, Inc.
CIK 0001785345
Entity typeother
Related Parties
1- filerCIK 0001944447
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 5:09 PM ET
- Size
- 5.5 KB